{"id":"W4282832327","doi":"10.1136/rmdopen-2022-002286","title":"Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2","year":2022,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Psoriatic arthritis; Visual analogue scale; Placebo; Internal medicine; Physical therapy; Quality of life (healthcare); Minimal clinically important difference; Dermatology Life Quality Index; Randomized controlled trial; Arthritis; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119313,0.0002158296,0.0009626478,0.0002094362,0.0002189671,0.00002409623,0.0001988521,0.00003017806,0.000478178],"category_scores_gemma":[0.00005961319,0.0001233163,0.0001638931,0.001500261,0.00006641823,0.00008359682,0.0002613706,0.0001516456,8.28519e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000167523,"about_ca_system_score_gemma":0.0001143373,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003133727,"about_ca_topic_score_gemma":0.002502664,"domain_scores_codex":[0.9981586,0.0001193704,0.0005556214,0.0003729925,0.0005333602,0.0002600097],"domain_scores_gemma":[0.9987343,0.00005251237,0.0004370063,0.0006003478,0.0001067696,0.00006905414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06222578,0.004701862,0.9127651,0.000006341241,0.005086386,0.0001007115,0.0005173096,0.00003218849,0.00000495107,0.000004224516,0.00004625805,0.0145089],"study_design_scores_gemma":[0.3442942,0.009756317,0.6423483,0.00004739968,0.0025371,0.000004064361,0.0004489324,0.00007812471,0.00005780773,0.00000339745,0.0002722419,0.0001520627],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952032,0.0001011861,0.000001053371,0.0001047251,0.0001008126,0.003736294,0.0002631994,0.00001530534,0.0004742011],"genre_scores_gemma":[0.9986295,0.00001218678,0.00007567368,0.0001156722,0.00000727832,0.0006264643,0.0002885397,0.00002515413,0.0002196005],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2820684,"threshold_uncertainty_score":0.5235714,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01291427857416632,"score_gpt":0.2761819780022461,"score_spread":0.2632676994280798,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}